120 related articles for article (PubMed ID: 751793)
1. Carcinogenicity tests in rats of two nitrosamines of high molecular weight, nitrosododecamethyleneimine and nitrosodi-n-octylamine.
Lijinsky W; Taylor HW
Ecotoxicol Environ Saf; 1978 Dec; 2(3-4):407-11. PubMed ID: 751793
[No Abstract] [Full Text] [Related]
2. Comparative carcinogenicity of some derivatives of nitrosodi-n-propylamine in rats.
Lijinsky W; Taylor HW
Ecotoxicol Environ Saf; 1978 Dec; 2(3-4):421-6. PubMed ID: 751794
[No Abstract] [Full Text] [Related]
3. N-Nitrosodi-n-propylamine.
Rep Carcinog; 2004; 11():III200-1. PubMed ID: 21089930
[No Abstract] [Full Text] [Related]
4. Carcinogenicity of methylated derivatives of N-nitrosodiethylamine and related compounds in Sprague-Dawley rats.
Lijinsky W; Taylor HW
J Natl Cancer Inst; 1979 Feb; 62(2):407-10. PubMed ID: 283272
[TBL] [Abstract][Full Text] [Related]
5. N-nitrosodi-n-butylamine.
Rep Carcinog; 2004; 11():III196-7. PubMed ID: 21089926
[No Abstract] [Full Text] [Related]
6. Carcinogenicity of nitrosododecamethyleneimine in NZR/Gd inbred rats.
Goodall CM; Lijinsky W
Carcinogenesis; 1984 Apr; 5(4):537-40. PubMed ID: 6705150
[TBL] [Abstract][Full Text] [Related]
7. N-Nitrosamines (15 listings): N-Nitrosodi-n-propylamine.
National Toxicology Program
Rep Carcinog; 2011; 12():310-1. PubMed ID: 21860508
[No Abstract] [Full Text] [Related]
8. N-Nitrosamines (15 listings): N-Nitrosodi-n-butylamine.
National Toxicology Program
Rep Carcinog; 2011; 12():303-4. PubMed ID: 21860504
[No Abstract] [Full Text] [Related]
9. The role of somatic mutations and cell replication kinetics in quantitative cancer risk assessment.
Moolgavkar SH; Luebeck EG
Prog Clin Biol Res; 1991; 369():469-79. PubMed ID: 1835095
[No Abstract] [Full Text] [Related]
10. Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone.
Hecht SS; Chen CB; Ohmori T; Hoffmann D
Cancer Res; 1980 Feb; 40(2):298-302. PubMed ID: 7356512
[TBL] [Abstract][Full Text] [Related]
11. Carcinogenicity test of two unstaurated derivatives of N-nitrosopiperdine in Sprague-Dawley rats.
Lijinsky W; Taylor HW
J Natl Cancer Inst; 1976 Dec; 57(6):1315-7. PubMed ID: 187801
[TBL] [Abstract][Full Text] [Related]
12. Carcinogenicity of proposed cancer chemotherapeutic agents with stilbene-arylnitrosamine structures.
Yamamoto RS; Richardson HL; Weisburger EK; Weisburger JH; Benjamin T; Bahner CT
J Natl Cancer Inst; 1973 Oct; 51(4):1313-5. PubMed ID: 4745859
[No Abstract] [Full Text] [Related]
13. N-Nitrososarcosine.
Rep Carcinog; 2004; 11():III208. PubMed ID: 21089938
[No Abstract] [Full Text] [Related]
14. N-Nitrosonornicotine.
Rep Carcinog; 2004; 11():III206. PubMed ID: 21089936
[No Abstract] [Full Text] [Related]
15. 4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone.
Rep Carcinog; 2004; 11():III202-3. PubMed ID: 21089932
[No Abstract] [Full Text] [Related]
16. The effect of substituents on the carcinogenicity of n-nitrosopyrrolidine in Sprague-Dawley rats.
Lijinsky W; Taylor HW
Cancer Res; 1976 Jun; 36(6):1988-90. PubMed ID: 178438
[TBL] [Abstract][Full Text] [Related]
17. N-Nitrosopiperidine.
Rep Carcinog; 2004; 11():III206-7. PubMed ID: 21105252
[No Abstract] [Full Text] [Related]
18. Effect of beta-oxidized nitrosamines on Syrian golden hamsters. I. 2-Hydroxy-propyl-n-propylnitrosamine.
Pour P; Krüger FW; Althoff J; Cardesa A; Mohr U
J Natl Cancer Inst; 1974 Apr; 52(4):1245-9. PubMed ID: 4826592
[No Abstract] [Full Text] [Related]
19. N-Nitrosomorpholine.
Rep Carcinog; 2004; 11():III205-6. PubMed ID: 21089935
[No Abstract] [Full Text] [Related]
20. N-Nitrosomethylvinylamine.
Rep Carcinog; 2004; 11():III204-5. PubMed ID: 21089934
[No Abstract] [Full Text] [Related]
[Next] [New Search]
